BMC Health Services Research

Table 3 Cost-effectiveness analysis for CVC, PICC and IVAP

From: Cost-utility analysis of different venous access devices in breast cancer patients: a decision-based analysis model

	6m DT				12m DT				More than 12m DT
	Cost^a($)	QALY	CER	ICER	Cost($)	QALY	CER	ICER	Cost($)	QALY	CER	ICER
CVC	542.36	0.24	2226.71	-	542.36	0.24	2226.71	-	542.36	0.24	2226.71	-
PICC	827.82	0.36	2275.74	^b2375.08	827.82	0.36	2275.74	^b2375.08	827.82	0.36	2275.74	^b2375.08
IVAP	1121.91	0.47	2407.77	^c2877.76	1320.06	0.94	1397.26	^c847.24	2043.12	2.69	758.99	^c522.01
				^b2606.08				^b1109.12				^b612.98

Note. DT:dwell time; m:month; QALY:Quality-Ajusted Life Years; CER:cost-effectiveness ratio; ICER:incremental cost-effectiveness ratio
^aThe average total cost; ^bCVC; ^cPICC

Back to article page

ISSN: 1472-6963

Contact us

General enquiries: journalsubmissions@springernature.com